<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38370099</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>Suppl 2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Descriptive epidemiology of poliomyelitis cases due to wild poliovirus type 1 and wild poliovirus type 3 in Nigeria, 2000-2020.</ArticleTitle><Pagination><StartPage>4</StartPage><MedlinePgn>4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.supp.2023.45.2.38079</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">in August 2020, the World Health Organization African Region was certified free of wild poliovirus (WPV) when Nigeria became the last African country to interrupt wild poliovirus transmission. The National Polio Emergency Operations Center instituted in 2012 to coordinate and manage Nigerian polio eradication efforts reviewed the epidemiology of WPV cases during 2000-2020 to document lessons learned.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">we analyzed reported WPV cases by serotype based on age, oral poliovirus vaccine immunization history, month and year of reported cases, and annual geographic distribution based on incidence rates at the Local Government Area level. The observed trends of cases were related to major events and the poliovirus vaccines used during mass vaccination campaigns within the analysis period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">a total of 3,579 WPV type 1 and 1,548 WPV type 3 laboratory-confirmed cases were reported with onset during 2000-2020. The highest WPV incidence rates per 100,000 population in Local Government Areas were 19.4, 12.0, and 11.3, all in 2006. Wild poliovirus cases were reported each year during 2000-2014; the endemic transmission went undetected throughout 2015 until the last cases in 2016. Ten events/milestones were highlighted, including insurgency in the northeast which led to a setback in 2016 with four cases from children previously trapped in security-compromised areas.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Nigeria interrupted WPV transmission despite the challenges faced because of the emergency management approach, implementation of mass vaccination campaigns, the commitment of the government agencies, support from global polio partners, and special strategies deployed to conduct vaccination and surveillance in the security-compromised areas.</AbstractText><CopyrightInformation>©Philip Bammeke et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bammeke</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamu</LastName><ForeName>Usman Said</ForeName><Initials>US</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolu</LastName><ForeName>Omotayo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waziri</LastName><ForeName>Ndadilnasiya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erberto</LastName><ForeName>Tesfaye</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>World Health Organization, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aregay</LastName><ForeName>Aron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nsubuga</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Global Public Health Solutions, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesen</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuaib</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023321">Poliovirus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023321" MajorTopicYN="Y">Poliovirus Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Polio eradication</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">emergency operations center</Keyword><Keyword MajorTopicYN="N">poliomyelitis</Keyword><Keyword MajorTopicYN="N">poliovirus vaccine</Keyword><Keyword MajorTopicYN="N">supplementary immunization</Keyword><Keyword MajorTopicYN="N">vaccination campaign</Keyword><Keyword MajorTopicYN="N">wild poliovirus</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38370099</ArticleId><ArticleId IdType="pmc">PMC10874097</ArticleId><ArticleId IdType="doi">10.11604/pamj.supp.2023.45.2.38079</ArticleId><ArticleId IdType="pii">PAMJ-45-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Minor PD. Live attenuated vaccines: Historical successes and current challenges. Virology. 2015 May;479-480:379–92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25864107</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (US) Forum on Emerging Infections . Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies: Workshop Summary. In: Knobler S, Lederberg J, Pray LA, editors. Washington (DC): National Academies Press (US); 2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">22764392</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M, Cochi S. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future. J Infect Dis. 2017 Jul 1;216(suppl_1):S1–S8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853839</ArticleId><ArticleId IdType="pubmed">28838196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretsinger K, Strebel P, Kezaala R, Goodson JL. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination. J Infect Dis. 2017 Jul 1;216(suppl_1):S308–S315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853258</ArticleId><ArticleId IdType="pubmed">28838195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL. Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication. J Infect Dis. 2014 Nov 1;210(Suppl 1(01)):S5–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615678</ArticleId><ArticleId IdType="pubmed">25316873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl S, Bhatnagar P, Sutter RW, Roesel S, Zaffran M. Global Polio Eradication-Way Ahead. Indian J Pediatr. 2018 Feb;85(2):124–131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5775388</ArticleId><ArticleId IdType="pubmed">29302865</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochi SL, Hegg L, Kaur A, Pandak C, Jafari H. The Global Polio Eradication Initiative: Progress, Lessons Learned, And Polio Legacy Transition Planning. Health Aff (Millwood) 2016 Feb;35(2):277–83.</Citation><ArticleIdList><ArticleId IdType="pubmed">26858381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochi SL, Jafari HS, Armstrong GL, Sutter RW, Linkins RW, Pallansch MA, et al. A world without polio. J Infect Dis. 2014 Nov 1;210(Suppl 1):S1–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10544861</ArticleId><ArticleId IdType="pubmed">25316822</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett DB, Llewellyn A, Singh H, Saxentoff E, Partridge J, Boualam L, et al. Progress Toward Poliovirus Containment Implementation-Worldwide, 2019-2020. MMWR Morb Mortal Wkly Rep. 2020 September 18;69(37):1330–1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498175</ArticleId><ArticleId IdType="pubmed">32941411</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa Regional Commission for the Certification of Poliomyelitis Eradication Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Lancet Glob Health. 2020 Oct;8(10):e1345–e1351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525084</ArticleId><ArticleId IdType="pubmed">32916086</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention Recommendations of the International Task Force for Disease Eradication. MMWR. 1993;42(No. RR-16):8. Accessed August 4, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">8145708</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamu US, Archer WR, Braka F, Damisa E, Siddique A, Baig S, et al. Progress Toward Poliomyelitis Eradication-Nigeria, January 2018-May 2019. MMWR Morb Mortal Wkly Rep. 2019 July 26;68(29):642–646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660103</ArticleId><ArticleId IdType="pubmed">31344023</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz RG, Mkanda P, Nsubuga P, Ado M, Etsano A. Public Health Innovations on the Way to Interruption of Poliovirus Transmission in Nigeria. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S65–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818554</ArticleId><ArticleId IdType="pubmed">26810368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, et al. Progress toward poliomyelitis eradication in Nigeria. J Infect Dis. 2014 Nov 1;210(Suppl 1):S40–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11177795</ArticleId><ArticleId IdType="pubmed">25316862</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig AS, Haydarov R, O'Malley H, Galway M, Dao H, Ngongo N, et al. The Public Health Legacy of Polio Eradication in Africa. J Infect Dis. 2017 July 1;216(suppl_1):S343–S350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853432</ArticleId><ArticleId IdType="pubmed">28838184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisu AW, Shuaib F, Johnson TM, Craig K, Fiona B, Banda R, et al. Profile of polio-compatible cases in Nigeria, 2006-20. BMC Public Health. 2018 Dec 13;18(Suppl 4):1308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291912</ArticleId><ArticleId IdType="pubmed">30541494</ArticleId></ArticleIdList></Reference><Reference><Citation>Warigon C, Mkanda P, Banda R, Zakari F, Damisa E, Idowu A, et al. The Journalists Initiatives on Immunisation Against Polio and Improved Acceptance of the Polio Vaccine in Northern Nigeria 2007-2015. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S86–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818555</ArticleId><ArticleId IdType="pubmed">26721745</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Progress toward poliomyelitis eradication-Nigeria, January 2004-July 2005. MMWR Morb Mortal Wkly Rep. 2005 Sep 9;54(35):873–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16151372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis. 2011 Apr 1;203(7):898–909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068031</ArticleId><ArticleId IdType="pubmed">21402542</ArticleId></ArticleIdList></Reference><Reference><Citation>Aylward B, Tangermann R. The global polio eradication initiative: lessons learned and prospects for success. Vaccine. 2011 Dec 30;29(Suppl 4):D80–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22486981</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Resurgence of wild poliovirus type 1 transmission and consequences of importation--21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep. 2006 Feb 17;55(6):145–50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Franka R, Higgins J, Kovacs SD, Forbi JC, Wassilak SGF, et al. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria. Risk Anal. 2021 Feb;41(2):289–302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814397</ArticleId><ArticleId IdType="pubmed">32348621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisu AW, Johnson TM, Craig K, Mkanda P, Banda R, Tegegne SG, et al. Strategies for Improving Polio Surveillance Performance in the Security-Challenged Nigerian States of Adamawa, Borno, and Yobe During 2009-2014. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S136–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818552</ArticleId><ArticleId IdType="pubmed">26655842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton LM, du Châtellier GM, Fournier-Caruana J, Ottosen A, Rubin J, Menning L, et al. Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio. J Infect Dis. 2017;1:216(suppl_1):S217–S225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853572</ArticleId><ArticleId IdType="pubmed">28838193</ArticleId></ArticleIdList></Reference><Reference><Citation>Garon J, Seib K, Orenstein WA, Ramirez Gonzalez A, Chang Blanc D, Zaffran M, et al. Polio endgame: the global switch from tOPV to bOPV. Expert Rev Vaccines. 2016 Jun;15(6):693–708.</Citation><ArticleIdList><ArticleId IdType="pubmed">26751187</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuaib FM, Musa PF, Muhammad A, Musa E, Nyanti S, Mkanda P, et al. Containment of Ebola and Polio in Low-Resource Settings Using Principles and Practices of Emergency Operations Centers in Public Health. J Public Health Manag Pract. 2017 Jan/Feb;23(1):3–10.</Citation><ArticleIdList><ArticleId IdType="pubmed">27488940</ArticleId></ArticleIdList></Reference><Reference><Citation>Nnadi C, Damisa E, Esapa L, Braka F, Waziri N, Siddique A, et al. Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas-Nigeria, 2016. MMWR Morb Mortal Wkly Rep. 2017 February 24;66(7):190–193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657850</ArticleId><ArticleId IdType="pubmed">28233765</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Adamu U, Adewara K, Aladeshawe A, Aregay A, Barau I, et al. Finding inhabited settlements and tracking vaccination progress: the application of satellite imagery analysis to guide the immunization response to confirmation of previously-undetected, ongoing endemic wild poliovirus transmission in Borno State, Nigeria. Int J Health Geogr. 2019 May 16;18(1):11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524248</ArticleId><ArticleId IdType="pubmed">31096971</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkwogu L, Shuaib F, Braka F, Mkanda P, Banda R, Korir C, et al. Impact of engaging security personnel on access and polio immunization outcomes in security-inaccessible areas in Borno state, Nigeria. BMC Public Health. 2018 December 13;18(Suppl 4):1311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292175</ArticleId><ArticleId IdType="pubmed">30541498</ArticleId></ArticleIdList></Reference><Reference><Citation>Touray K, Mkanda P, Tegegn SG, Nsubuga P, Erbeto TB, Banda R, et al. Tracking Vaccination Teams During Polio Campaigns in Northern Nigeria by Use of Geographic Information System Technology: 2013-2015. J Infect Dis. 2016 May 1;213(Suppl 3(Suppl 3)):S67–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818548</ArticleId><ArticleId IdType="pubmed">26609004</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Ent MMVX, Mallya A, Sandhu H, Anya BP, Yusuf N, Ntakibirora M. Experiences and Lessons From Polio Eradication Applied to Immunization in 10 Focus Countries of the Polio Endgame Strategic Plan. J Infect Dis. 2017 Jul 1;216(suppl_1):S250–S259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853381</ArticleId><ArticleId IdType="pubmed">28838187</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleringer S, Abdelwahab J, Vandenent M. Polio supplementary immunization activities and equity in access to vaccination: evidence from the demographic and health surveys. J Infect Dis. 2014 Nov 1;210(Suppl 1):S531–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316877</ArticleId></ArticleIdList></Reference><Reference><Citation>Andre M, Wolff CG, Tangermann RH, Chenoweth P, Tallis G, Kamgang JB, et al. Assessing and mitigating the risks for polio outbreaks in polio-free countries-Africa, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014 August 29;63(34):756–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779440</ArticleId><ArticleId IdType="pubmed">25166927</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwahab J, Dietz V, Eggers R, Maher C, Olaniran M, Sandhu H, Vandelaer J. Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability. J Infect Dis. 2014 Nov 1;210(Suppl 1):S498–503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617671</ArticleId><ArticleId IdType="pubmed">25316872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Why Have cVDPV2 Outbreaks Increased Globally After the Polio Immunization Strategy Switch: Challenges for the Polio Eradication Endgame. China CDC Wkly. 2020 Mar 14;2(11):176–179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8393165</ArticleId><ArticleId IdType="pubmed">34594619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>